Ceforanide

Ceforanide

Clinical data
Routes of administration	Intramuscular
ATC code	J01DC11 (WHO)
Pharmacokinetic data
Protein binding	80.6%
Metabolism	Nil
Elimination half-life	2.6 to 2.98 hours
Excretion	Renal
Identifiers
IUPAC name (6R,7R)-7-{[2-[2-(aminomethyl)phenyl]acetyl]amino}-3- {[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	60925-61-3
PubChem CID	43507
DrugBank	APRD00853
ChemSpider	39656 Y
UNII	8M1YF8951V
KEGG	D00259 N
ChEBI	CHEBI:3495
ChEMBL	ChEMBL1201046 N
CompTox Dashboard (EPA)	DTXSID1022760
Chemical and physical data
Formula	C20H21N7O6S2
Molar mass	519.556 g/mol g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)Cc3ccccc3CN)CSc4nnnn4CC(=O)O)C(=O)O
InChI InChI=1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1 Y Key:SLAYUXIURFNXPG-CRAIPNDOSA-N Y
NY (what is this?)  (verify)

Ceforanide is a second-generation cephalosporin antibiotic.

External links

• Crowle A, Sbarbaro J, May M (1988). "Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages". Tubercle. 69 (1): 15–25. doi:10.1016/0041-3879(88)90036-0. PMID 3140456.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• Campoli-Richards D, Lackner T, Monk J (1987). "Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy". Drugs. 34 (4): 411–37. PMID 3315624.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• Cone L, Barton S, Woodard D (1987). "Treatment of scleroma with ceforanide". Arch Otolaryngol Head Neck Surg. 113 (4): 374–6. PMID 3814386.{{cite journal}}: CS1 maint: multiple names: authors list (link)